References
- Le Duc J. Epidemiology of viral hemorrhagic fever viruses. Rev Infect Dis, Suppl 1989; 4: 730–735
- Viral hemorrhagic fever. Report of a WHO Committee. 1985; 721
- Centers for Disease Control. Management of patients with suspected viral hemorrhagic fever. MMWR 1988; 37(Suppl 3)1–15
- Mahdy M S, Chiang W, McLanghlin B, Derksen K, Truxton B H, Neg K. Lassa fever: The first confirmed case imported into Canada. Canada Diseases Weekly Rep 1990; 15: 193–198
- Johnsson K M. African hemorrhagic fevers caused by Marburg and Ebola viruses. Viral infectons in humans, A S Evans. Plenum Publishing Corp., New York 1989; 95–103
- Memorandum on the contest of viral hemorrhagic fevers. HHSO, London 1986
- In Marburg virus disease, G A Martini, R Siegert. Springer‐Verlag, Berlin 1971; 1–9
- Hennessen W. A hemorrhagic disease transmitted from monkeys to man. Natl Cancer First Monograph 1968; 29: 161–171
- Gear J SS, Cassel G A, Gear A J, Trappler B, Clausen L, Meyers A M, Kew M C, Bothwell T H, Sher R, Miller G B, Schneider J, Koornhof H J, Gomperts E D, Isaacson M, Gear J HS. Outbreak of Marburg disease in Johannisberg. Br Med J 1975; 4: 489–493
- Smith D H, Isaacson M, Johnson K M, Bagshawe A, Johnson B K, Swanapoel R, Killey M, Siongok T, Keruga W K. Marburg‐virus disease in Kenya. Lancet 1982; 1: 816–820
- World Health Organization. Viral hemorrhagic fever surveillance. Wkly Epid Record 1982; 57: 359
- Jahrling P B, Geisbert T W, Dalgard D W, Johnson E D, Ksiazek T G, Hall W C, Peters C J. Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet 1990; 335: 502–505
- Sureau P H. Firsthand clinical observations of hemorrhagic manifestations in Ebola hemorrhagic fever in Zaire. Rev Infect Dis, Suppl 1989; 4: 790–793
- Ebola hemorrhagic fever in Zaire, 1976: Report of an international commission. Bull WHO 1978; 56: 271–293
- Ebola hemorrhagic fever in Sudan, 1976. Bull WHO 1978; 56: 247–270
- Martini G A. Marburg virus disease. Postgrad Med J 1973; 49: 542–546
- Huggins J W. Prospects for treatment of viral hemorrhagic fever with ribavirin, a broad‐spectrum antiviral drug. Rev Infect Dis, Suppl 1989; 4: 750–761
- Morrill J C, Jennings G B, Cosgriff T M, Gibbs P H, Peters C J. Prevention of Rift Valley fever in Rhesus monkeys with interferon‐α. Rev Infect Dis, Suppl 1989; 4: 815–825
- Levin S, Hahn T, Rosenberg H, Bino T. Treatment of life‐threatening viral infections with interferon‐α: pharmacokinetic studies in a clinical trial. J Med Sci 1982; 18: 439–446
- Neuman‐Haefelin D, Shrestha B, Manthey K F. Effective antiviral prophylaxis and therapy by systemic application of human interferon in immunosuppressed monkeys. J Infect Dis 1976; 133: A211–215, Suppl
- Galvani D, Griffiths S D, Cawley J C. Interferon for treatment: the dust settles. Br Med J 1988; 296: 1554–1556
- Wulff H, Johnsson K M. Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa and Marburg virus infection. Bull WHO 1979; 57: 631–635
- Siegert R, Schu H L, Siencka W. Isolierung und Identifizierung des Marburg Virus. Dtsch Med Wochenschr 1968; 93: 604–612
- Johnson K M, Webb P A, Heymann D L. Evaluation of plasma‐pheresis program in Zaire. Ebola virus hemorrhagic fever, S R Pattyn. Elsevier/North‐Holland, New York 1978; 219–222
- Wulff H, Conrad L. Marburg disease. Comparative diagnosis of viral disease, E Kurstak, C Kurstak. Academic Press, New York 1977; 3–33